Decoy Therapeutics Director Patricia Gauthier Receives 2,000 Shares

What Happened
Patricia Gauthier, a director of Decoy Therapeutics Inc. (DCOY), was granted 2,000 restricted shares on August 31, 2026. The shares were issued at $0.00 (award/grant) for a reported aggregate value of $0. This was an equity award (code A), not an open-market purchase or sale — a form of compensation rather than a direct bullish purchase.

Key Details

• Transaction date: August 31, 2026; Form 4 filed September 2, 2026 (timely filing).
• Shares granted: 2,000; Acquisition price reported: $0.00; aggregate reported value: $0.
• Vesting: 100% of the restricted stock will vest on August 30, 2027 (per footnote).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Transaction type/code: Award/grant (A). No 10b5-1 plan, tax-withholding, or sale reported in this filing.

Context
Restricted stock grants to directors are common compensation and typically vest over time; they do not necessarily indicate the director bought shares on the open market. The one-year vesting schedule means the shares remain subject to forfeiture until August 30, 2027, after which they become fully owned if vesting conditions are met.